Protagonist Therapeutics, Inc.
$128.75
-7.80 (-5.71%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -10.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -18.8%
Own PTGX?
See how PTGX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.